Income Statement
BIOTE CORP.
BTMD
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
192.22 | 197.19 | 185.36 | 164.96 | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
192.22 | 197.19 | 185.36 | 164.96 | - |
|
Operating Expenses
|
101.81 | 107.45 | 98.83 | 165.50 | 0.00 |
|
Research & Development
|
- | - | - | - | - |
|
Selling, General & Administrative
|
101.81 | 107.45 | 98.83 | 165.50 | - |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
90.41 | 89.74 | 86.53 | -0.55 | - |
|
Non-Operating Income
|
2.03 | -30.60 | -28.78 | 62.43 | - |
|
Interest Income
|
0.90 | 2.00 | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
-0.03 | 0.01 | -0.02 | - | - |
|
Income Before Tax
|
37.58 | 1.02 | -0.12 | 1.71 | - |
|
Income Tax Expense
|
10.54 | -2.14 | -3.44 | 2.68 | - |
|
Non-Controlling Interest
|
4.55 | -3.11 | -6.12 | 2.29 | - |
|
Net Income
|
27.05 | 3.16 | 3.32 | -0.97 | 11.11 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
94.08 | 93.32 | 89.53 | 1.65 | 0.00 |
|
Earnings Per Share (Basic)
|
0.86 | 0.09 | 0.13 | -0.12 | 0.33 |
|
Diluted EPS
|
0.74 | 0.09 | 0.13 | -0.12 | 0.32 |
|
Weighted Average Shares
|
31.28 | 34.27 | 25.71 | 8.06 | 26.27 |
|
Diluted Weighted Avg Shares
|
36.67 | 34.27 | 25.71 | 8.06 | 26.27 |
|
Comprehensive Income
|
31.60 | 0.03 | -2.80 | 1.32 | - |